Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.46 SEK | +2.02% |
|
+4.71% | +84.96% |
06-27 | Hansa Biopharma AB Announces Board Appointments | CI |
05-31 | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
HANSA BIOPHARMA AB | Other Biotechnology & Medical Research | +2.02% | +4.71% | +84.96% | +16.21% | -73.06% | 313M | ![]() | ![]() | ![]() |
Technical Rankings Surperformance
- Stock Market
- Equities
- HNSA Stock
- Charts Hansa Biopharma AB
- Comparison Chart